Artes Medical Enforces Its Patent Rights Against BioForm Medical in Europe.SAN DIEGO San Diego (săn dēā`gō), city (1990 pop. 1,110,549), seat of San Diego co., S Calif., on San Diego Bay; inc. 1850. San Diego includes the unincorporated communities of La Jolla and Spring Valley. Coronado is across the bay. -- Artes Medical, Inc., a privately-held specialty pharmaceutical and medical device company, announced today that it has filed a patent infringement patent infringement n. the manufacture and/or use of an invention or improvement for which someone else owns a patent issued by the government, without obtaining permission of the owner of the patent by contract, license or waiver. lawsuit in Frankfurt, Germany against BioForm Medical Europe B.V. and BioForm Medical, Inc. for infringement of European Patent 0 406 375. Artes Medical also announced that that one of its founders and an inventor of Artes' patented Microsphere Not to be confused with Glass microphere. This article largely refers to micropheres or protein protocells as small spherical units postulated by some scientists as a key stage in the origin of life. technology, Dr. Martin Lemperle, has filed a lawsuit in Frankfurt, Germany against BioForm Medical, Inc. The lawsuit seeks a ruling from the German Federal District court declaring that Dr. Lemperle's assignment of U.S. Patent No. 5,344,452 to Artes Medical, Inc. on January 22, 2000 did not violate the terms of a patent license agreement between Dr. Lemperle and BioForm's alleged predecessor-in-interest, Bristol-Myers Squibb Bristol-Myers Squibb (NYSE: BMY), colloquially referred to as BMS, is a pharmaceutical corporation, formed by a 1989 merger between pharmaceutical companies Bristol-Myers Company, founded in 1887 by William McLaren Bristol and John Ripley Myers in Clinton, NY (both were Company. The lawsuit also seeks a ruling that on May 28, 2003, Dr. Lemperle validly terminated any purported license owned by BioForm because BioForm exceeded the scope of any license grant by marketing its Radiance and Radiesse products to treat wrinkles and other skin depressions. "As we did in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. , we are moving forward in Germany to enforce our patent rights and prevent any unauthorized sales and marketing of products covered by our patents. Artes has made substantial investments in research, development and U.S. clinical trials for its product aimed at treating skin depressions, ArteFill. Though litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. was not our first choice, we owe it to our shareholders to preserve their investment in our groundbreaking platform technology. We intend to enforce our patents vigorously," said Dr. Stefan Lemperle, co-founder and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Artes Medical. About Artes Medical Artes Medical helps physicians in the facial aesthetics market significantly improve patient outcomes and partners with physicians to build their practices. The company's lead product is ArteFill(TM). ArteFill is a unique combination of precision filtered synthetic microspheres (20%) and Ultra-Purified Collagen(TM) (80%). After ArteFill is injected, the microscopic spheres stimulate the body's own natural collagen production to replace the purified collagen. The autologous autologous /au·tol·o·gous/ (aw-tol´ah-gus) related to self; belonging to the same organism. au·tol·o·gous adj. 1. collagen builds volume and encapsulates each permanent microscopic sphere to achieve long-lasting wrinkle correction. The ArteFill Progressive Enhancement Procedure(TM) allows for treatment in stages, giving patients the exact look they desire, and will only be available from Artes-certified physicians. ArteFill received an approvable letter from the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. in January 2004. Once ArteFill receives final approval, it will be the only FDA-approved permanent injectable treatment for facial wrinkles on the market today. Over the last decade Artecoll, ArteFill's predecessor, has been used in over 250,000 patients outside the United States to correct a wide variety of facial wrinkles and scars. For more information about the company and its products, visit the company's website www.artesmedical.com. Artes Medical, Artecoll, ArteFill, Ultra-Purified Collagen and ArteFill Progressive Enhancement Procedure are trademarks of Artes Medical USA, Inc. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion